骨髓
医学
血细胞
细胞
药品
癌症研究
药理学
免疫学
化学
生物化学
作者
Anzhi Hu,Huijuan Chen,Jing Liang,Cong Liu,Fanzhu Li,Chaofeng Mu
标识
DOI:10.1016/j.jconrel.2021.09.018
摘要
Cell-based therapies could overcome the limitations of traditional drugs for the treatment of refractory diseases. Cell exchange between the bone marrow and blood is bidirectional. Several kinds of cells in the blood have the capability to enter the bone marrow by interacting with sinusoidal cells under specific physiological or pathological conditions. These cells are the potential living therapeutics or delivery vehicles to treat or prevent bone marrow-related hematologic diseases. In this review, we summarized the in vivo molecular mechanisms and kinetics of these cells in entering the bone marrow. The advances in the fabrication of living cell drugs and the strategies to design cell-based carriers into the bone marrow were discussed. The latest studies on how to use blood cells as living drugs or as drug carriers to improve therapeutic outcomes of hematologic diseases inside the bone marrow were highlighted.
科研通智能强力驱动
Strongly Powered by AbleSci AI